However, expression of constitutively active RhoA, specifically in podocytes, causes proteinuria and FSGS in mice (Zhu et al, 2011); overexpression of dominant-negative RhoA also develops albuminuria and foot process effacement (Wang et al, 2012). The gene discussed is RHOA; the disease is focal segmental glomerulosclerosis.